This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Min Hu: Advancements in Cancer Diagnosis
Introduction: Min Hu, a notable inventor based in Brighton, MA, has made significant strides in the field of cancer research through his innovative patent. With a focus on gene methylation and expression, his work is paving the way for potential advancements in diagnostics and treatment.
Latest Patents: Min Hu holds a patent for his invention titled "Gene Methylation and Expression." This invention presents a method for analyzing the methylation status of all or part of an entire genome. Furthermore, it includes techniques and reagents for characterizing biological cells that contain DNA prone to methylation. These methodologies are particularly instrumental in the diagnosis of cancer, including breast cancer, showcasing their invaluable contribution to medical research.
Career Highlights: Min Hu is currently employed at the Dana-Farber Cancer Institute, Inc., a renowned research institution dedicated to cancer treatment and prevention. His role at the institute underscores his commitment to advancing cancer research and improving patient outcomes through novel approaches in genomics.
Collaborations: Throughout his career, Min has collaborated with esteemed colleagues, including Kornelia Polyak and Noga Qimron. These partnerships are instrumental in driving forward innovative research projects and fostering a collaborative environment aimed at addressing the complex challenges in cancer therapy.
Conclusion: Min Hu's contributions to the field of cancer diagnostics through his patent on gene methylation demonstrate the remarkable potential of innovative thinking in transforming healthcare. His work not only aids in the understanding of cancer biology but also enhances the tools available for early diagnosis and treatment, exemplifying the impact that dedicated inventors can have on society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
